Related Experiment Video
Updated: Jun 17, 2025

Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice
Published on: December 16, 2021
Enthesitis in IBD Patients.
Ivna Akrapovic Olic1,2, Jonatan Vukovic1,2, Mislav Radic1,3
1Internal Medicine Department, University of Split School of Medicine, Soltanska 2, 21000 Split, Croatia.
Inflammatory bowel disease (IBD) patients often have spondyloarthritis (SpA) with enthesitis. Early ultrasound detection of this underappreciated extraintestinal manifestation in IBD can guide timely treatment.
Area of Science:
- Gastroenterology
- Rheumatology
- Medical Imaging
Background:
- Inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, is characterized by chronic gastrointestinal inflammation.
- Extraintestinal manifestations (EIMs) are common in IBD, with spondyloarthritis (SpA) being the most frequent.
- Enthesitis, inflammation at the insertion sites of tendons and ligaments, is a key feature of SpA but often overlooked in IBD.
Purpose of the Study:
- To review current knowledge on enthesitis in IBD patients within IBD-SpA cohorts.
- To highlight the significance of enthesitis as an underappreciated EIM in IBD.
- To emphasize the potential of ultrasound for early detection of subclinical enthesitis.
Main Methods:
- Narrative review of existing literature on IBD-SpA cohorts.
- Focus on studies reporting enthesitis as an EIM.
- Assessment of ultrasound's role in detecting enthesitis.
Main Results:
- SpA is a common comorbidity in IBD patients.
- Enthesitis is a prevalent but often underestimated EIM in IBD.
- Ultrasound is a feasible and accessible tool for identifying enthesitis.
Conclusions:
- Early detection of enthesitis in IBD patients using ultrasound is crucial.
- Timely intervention for enthesitis can potentially improve outcomes for IBD patients.
- Further research on IBD-SpA cohorts focusing on enthesitis is warranted.
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...

